by 
The menstrual cramps treatment market comprises products that provide relief from painful uterine cramps experienced during menstruation. Traditional over-the-counter pain relievers containing NSAIDs like ibuprofen are commonly used to tackle menstrual cramps. However, there has been a growing demand for alternative therapy options due to side effects associated with painkillers.
The Global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.3 Mn in 2024 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other. The growing awareness regarding the side effects of painkillers and increased focus on herbal remedies for menstrual cramps is fueling the demand for alternative therapy options in the market. Several companies are expanding their global footprint to tap the growing demand for menstrual cramps treatment products in developing nations across Asia Pacific and Latin America.
Market Key Trends
Herbal supplements containing ingredients like ginger, turmeric, chamomile etc. are gaining popularity as a safer alternative to treat menstrual cramps. Ginger contains anti-inflammatory properties that help relieve menstrual pain. Turmeric is another herbs known for its antioxidant and anti-inflammatory qualities. Clinical studies have proved the effectiveness of herbal supplements in reducing the intensity of menstrual cramps with no major side effects. The trend of herbal remedies is expected to drive the growth of the menstrual cramps treatment market during the forecast period.
Porter’s Analysis
Threat of new entrants: The established players already hold majority market share with strong distribution networks and resources. New entrants will face high entry barriers.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and presence of many players in the market.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to industry being dominated by few large players who source materials in bulk.
Threat of new substitutes: Threat of substitute is low as there are limited treatment options for menstrual cramps currently.
Competitive rivalry: The market is highly competitive due to presence of many global and regional players competing on basis of product quality, pricing and innovation.
Geographical Regions
North America holds largest share currently accounting for over 40% of global market value due to wide availability of treatment options, rising awareness and high healthcare expenditure.
Asia Pacific is fastest growing region for menstrual cramps treatment market driven by rapidly increasing population, changing lifestyles and growing focus towards women healthcare in emerging countries like India and China. Favourable regulatory landscape and developing healthcare infrastructure will also boost regional market growth over forecast period.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
